EUROPEAN MARKETS FOR PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY AND CORONARY STENTING PRODUCTS

503 Pages | 231 Exhibits | 2005 Analysis | Forecasts Through 2011 Product Family: Market Reports




OVERVIEW:
Coronary artery disease is the leading cause of death in Europe. The morbidity/mortality rates associated with the disease continue to fuel the demand for percutaneous transluminal coronary angioplasty (PTCA) and coronary stenting products--particularly drug-eluting stents--to treat advanced cases that cannot be adequately managed with medical therapy.

Sales of PTCA products and coronary stents and stent systems in Europe reached approximately $1.4 billion in 2004. Growing at a healthy compound annual rate of 7.6%, sales of these products are projected to climb to $2.4 billion in the year 2011.

This dynamic report from Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the European markets for PTCA and coronary stenting products. Covered topics in this report include arterial access site closure devices; bare-metal stents; coronary artery disease management; coronary guiding catheters; coronary guidewires; coronary stent coatings, configurations, and materials; drug-eluting stents; inflation devices; introducers/sheaths; European national healthcare markets; PTCA balloon catheters; PTCA and coronary stenting procedure volumes; population and healthcare-related statistics; and technological developments in PTCA and coronary stenting.

TABLE OF CONTENTS:

EXECUTIVE SUMMARY

i.   European Healthcare Markets

ii.   Coronary Artery Disease Management

iii.  Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting, Procedure Volumes

iv.  Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting Products Market

v.  Percutaneous Transluminal Coronary Angioplasty Products Market Segment

a.  Balloon Catheters

b.  Coronary Guiding Catheters

c.  Coronary Guidewires

d.  Introducers/Sheaths

e.  Inflation Devices

f.   Arterial Access Site Closure Devices

vi.  Coronary Stents and Stent Systems Market Segment

a.  Bare-Metal Stent Products

b.  Drug-Eluting Stent Products

vii. Methodology

 

Exhibit ES-1:    European Union, Population Statistics Comparison, 1994 and 2004

Exhibit ES-2:    Men, Number of Deaths due to Cardiovascular Diseases/Disorders, Selected European Countries

Exhibit ES-3:    Women, Number of Deaths due to Cardiovascular Diseases/Disorders, Selected European Countries

Exhibit ES-4:    Europe, Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting, Historic Procedures Volumes, 1997-2003

Exhibit ES-5:    Europe, Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting, Forecast Procedures Volumes, 2004-2011

Exhibit ES-6:    Europe, Coronary Stent Placements, Historic and Forecast, 1997-2011

Exhibit ES-7:    France, Coronary Stent Placements, Historic and Forecast, 1997-2011

ExhibitES-8:     Germany, Coronary Stent Placements, Historic and Forecast, 1997-2011

Exhibit ES-9:    Italy, Coronary Stent Placements, Historic and Forecast, 1997-2011

Exhibit ES-10:   Spain, Coronary Stent Placements, Historic and Forecast, 1997-2011

Exhibit ES-11:   United Kingdom, Coronary Stent Placements, Historic and Forecast, 1997-2011

Exhibit ES-12:   Benelux, Coronary Stent Placements, Historic and Forecast, 1997-2011

Exhibit ES-13:   Rest of Europe, Coronary Stent Placements, Historic and Forecast, 1997-2011

Exhibit ES-14:   Europe, Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting Products, Market Forecast, 2004-2011

Exhibit ES-15:   Europe, Percutaneous Transluminal Coronary Angioplasty Products, Market Forecast, 2004-2011

Exhibit ES-16:   Europe, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters, Market Forecast, 2004-2011

Exhibit ES-17:   Europe, Coronary Guiding Catheters, Market Forecast, 2004-2011

Exhibit ES-18:   Europe, Coronary Guidewires, Market Forecast, 2004-2011

Exhibit ES-19:   Europe, Introducers/Sheaths, Market Forecast, 2004-2011

Exhibit ES-20:   Europe, Inflation Devices, Market Forecast, 2004-2011

Exhibit ES-21:   Europe, Arterial Access Site Closure Devices, Market Forecast, 2004-2011

Exhibit ES-22:   Europe, Coronary Stents/Stent Systems, Market Forecast, 2004-2011

Exhibit ES-23:   Europe, Bare-Metal Stents, Market Forecast, 2004-2011

Exhibit ES-24:   Europe, Drug-Eluting Stents, Market Forecast, 2004-2011

 

1. EUROPEAN HEALTHCARE MARKETS

1.1 The European Union

1.1.1 A Common Currency

1.1.2 Regulatory Policies

1.1.3 Reimbursement

1.1.4 Healthcare Spending

1.2 Selected European National Healthcare Profiles

1.2.1 France

1.2.1.1 Healthcare Organization and Reform

1.2.1.2 Hospital Services

1.2.1.3 Medical Device Reimbursement

1.2.2 Germany

1.2.2.1 Healthcare Organization and Reform

1.2.2.2 Hospital Services

1.2.2.3 Medical Device Reimbursement

1.2.3 Italy

1.2.3.1 Healthcare Organization and Reform

1.2.3.2 Hospital Services

1.2.3.3 Medical Device Reimbursement

1.2.4 Spain

1.2.4.1 Healthcare Organization and Reform

1.2.4.2 Hospital Services

1.2.4.3 Medical Device Reimbursement

1.2.5 United Kingdom

1.2.5.1 Healthcare Organization and Reform

1.2.5.2 Hospital Services

1.2.5.3 Medical Device Reimbursement

1.2.6 Benelux

1.2.6.1 Healthcare Organization and Reform

1.2.6.2 Hospital Services

1.2.6.3 Medical Device Reimbursement Structure

 

Exhibit 1-1:    European Union, Medical Devices Risk Classification System

Exhibit 1-2:    European Union, Population Statistics Comparison, 1994 and 2004

Exhibit 1-3:    France, Selected National Healthcare Statistics

Exhibit 1-4:    Germany, Selected National Healthcare Statistics

Exhibit 1-5:    Italy, Selected National Healthcare Statistics

Exhibit 1-6:    Spain, Selected National Healthcare Statistics

Exhibit 1-7:    United Kingdom, Selected National Healthcare Statistics

Exhibit 1-8:    Belgium, Selected National Healthcare Statistics

Exhibit 1-9:    The Netherlands, Selected National Healthcare Statistics

Exhibit 1-10:  Luxembourg, Selected National Healthcare Statistics

 

2. CORONARY HEART DISEASE OVERVIEW

2.1 Coronary Heart Disease

2.1.1 Atherosclerosis

2.1.1.1 Description

2.1.1.2 Statistics

2.1.2 Angina Pectoris

2.1.2.1 Description

2.1.2.2 Statistics

2.1.3 Myocardial Infarction

2.1.3.1 Description

2.1.3.2 Statistics

2.2 Disease Management

2.2.1 Medical Management

2.2.1.1 Lifestyle Changes

2.2.1.1.1 Diet Modification

2.2.1.1.2 Smoking Cessation

2.2.1.2 Pharmaceuticals

2.2.1.2.1 Anticoagulants and Antiplatelet Drugs

2.2.1.2.2 Lipid-Lowering Drugs

2.2.1.2.3 Anti-Hypertensive Drugs

2.2.1.2.4 Nitroglycerin Preparations

2.2.2 Surgical Intervention

2.2.2.1 Coronary Artery Bypass Graft Surgery

2.2.2.2 Transmyocardial Revascularization

2.2.3 Percutaneous Coronary Interventions

2.2.3.1 Percutaneous Transluminal Coronary Angioplasty

2.2.3.2 Coronary Stenting

 

Exhibit 2-1:    Men, Number of Deaths due to Cardiovascular Diseases/Disorders, Selected European Countries

Exhibit 2-2:    Women, Number of Deaths due to Cardiovascular Diseases/Disorders, Selected European Countries

Exhibit 2-3:    Europe, Total Cholesterol and High-Cholesterol Prevalence, Selected MONICA Project Populations, by Gender Group

Exhibit 2-4:    Standard Angina Pectoris Classification

Exhibit 2-5:    Europe, Coronary Events Incidence Rates, Selected MONICA Project Populations, by Gender Group

Exhibit 2-6:    2001, Percentage of Total Energy Intake Provided by Fats and Fruits/Vegetables in the Populations of Selected European Countries

Exhibit 2-7:    Tobacco Smoking, Prevalence in Selected European Countries, by Gender Group

Exhibit 2-8:    Europe, Selected Pharmaceutical Preparations Prescribed for Hospital Patients with Coronary Heart Disease, by Geographic Region

Exhibit 2-9:    2000, Open-Heart and Coronary Artery Bypass Graft Surgery, Procedure Rates per Million Population, Selected European Countries

 

3. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY PRODUCTS MARKET

3.1 Percutaneous Transluminal Coronary Angioplasty Technique

3.1.1 Approaches

3.1.2 Applications

3.1.3 Efficacy

3.1.4 Complications

3.1.5 Adjunctive Anti-Clotting Drug Therapies

3.1.6 Embolic Protection Strategies

3.1.6.1 Distal Filter Devices

3.1.6.2 Distal Balloon Occlusion Devices

3.1.6.3 Proximal Balloon Occlusion Devices

3.1.7 Procedure Volumes

3.1.7.1 France

3.1.7.2 Germany

3.1.7.3 Italy

3.1.7.4 Spain

3.1.7.5 United Kingdom

3.1.7.6 Benelux

3.1.7.7 Rest of Europe

3.2 Percutaneous Transluminal Coronary Angioplasty Products

3.2.1 Product Pricing

3.2.2 Market Overview

3.2.2.1 Market Drivers

3.2.2.2 Market Limiters

3.2.2.3 National Markets

3.2.2.4 Competitors

3.2.3 Balloon Catheters

3.2.3.1 Market Forecast

3.2.3.2 Competitive Analysis

3.2.4 Coronary Guiding Catheters

3.2.4.1 Market Forecast

3.2.4.2 Competitive Analysis

3.2.5 Coronary Guidewires

3.2.5.1 Market Forecast

3.2.5.2 Competitive Analysis

3.2.6 Introducers/Sheaths

3.2.6.1 Market Forecast

3.2.6.2 Competitive Analysis

3.2.7 Inflation Devices

3.2.7.1 Market Forecast

3.2.7.2 Competitive Analysis

3.2.8 Arterial Access Site Closure Devices

3.2.8.1 Market Forecast

3.2.8.2 Competitive Analysis

 

Exhibit 3-1:      Europe, Percutaneous Transluminal Coronary Angioplasty, Historic Procedure Volumes, by Country 1997-2003

Exhibit 3-2:      2004, Europe, Percutaneous Transluminal Coronary Angioplasty Procedure Rates per Million Inhabitants, by Country

Exhibit 3-3:      Europe, Percutaneous Transluminal Coronary Angioplasty, Procedure Volumes Forecast, by Country, 2004-2011

Exhibit 3-4:      France, Percutaneous Transluminal Coronary Angioplasty, Historic and Forecast Procedure Volumes, 1997-2011

Exhibit 3-5:      Germany, Percutaneous Transluminal Coronary Angioplasty, Historic and Forecast Procedure Volumes, 1997-2011

Exhibit 3-6:      Italy, Percutaneous Transluminal Coronary Angioplasty, Historic and Forecast Procedure Volumes, 1997-2011

Exhibit 3-7:      Spain, Percutaneous Transluminal Coronary Angioplasty, Historic and Forecast Procedure Volumes, 1997-2011

Exhibit 3-8:      United Kingdom, Percutaneous Transluminal Coronary Angioplasty, Historic and Forecast Procedure Volumes, 1997-2011

Exhibit 3-9:      Benelux, Percutaneous Transluminal Coronary Angioplasty, Historic and Forecast Procedure Volumes, 1997-2011

Exhibit 3-10:     Rest of Europe, Percutaneous Transluminal Coronary Angioplasty, Historic and Forecast Procedure Volumes, 1997-2011

Exhibit 3-11:     2004, Europe, Estimated Consumables Cost per Percutaneous Transluminal Coronary Angioplasty Procedure

Exhibit 3-12:     Europe, Percutaneous Transluminal Coronary Angioplasty Products, Market Forecast, 2004-2011

Exhibit 3-13:     France, Percutaneous Transluminal Coronary Angioplasty Products, Market Forecast, 2004-2011

Exhibit 3-14:     Germany, Percutaneous Transluminal Coronary Angioplasty Products, Market Forecast, 2004-2011

Exhibit 3-15:     Italy, Percutaneous Transluminal Coronary Angioplasty Products, Market Forecast, 2004-2011

Exhibit 3-16:     Spain, Percutaneous Transluminal Coronary Angioplasty Products, Market Forecast, 2004-2011

Exhibit 3-17:     United Kingdom, Percutaneous Transluminal Coronary Angioplasty Products, Market Forecast, 2004-2011

Exhibit 3-18:     Benelux, Percutaneous Transluminal Coronary Angioplasty Products, Market Forecast, 2004-2011

Exhibit 3-19:     Rest of Europe, Percutaneous Transluminal Coronary Angioplasty Products, Market Forecast, 2004-2011

Exhibit 3-20:     2004, Europe, Percutaneous Transluminal Coronary Angioplasty Products Market, Share by Supplier

Exhibit 3-21:     2004, France, Percutaneous Transluminal Coronary Angioplasty Products Market, Share by Supplier

Exhibit 3-22:     2004, Germany, Percutaneous Transluminal Coronary Angioplasty Products Market, Share by Supplier

Exhibit 3-23:     2004, Italy, Percutaneous Transluminal Coronary Angioplasty Products Market, Share by Supplier

Exhibit 3-24:     2004, Spain, Percutaneous Transluminal Coronary Angioplasty Products Market, Share by Supplier

Exhibit 3-25:     2004, United Kingdom, Percutaneous Transluminal Coronary Angioplasty Products Market, Share by Supplier

Exhibit 3-26:     2004, Benelux, Percutaneous Transluminal Coronary Angioplasty Products Market, Share by Supplier

Exhibit 3-27:     2004, Rest of Europe, Percutaneous Transluminal Coronary Angioplasty Products Market, Share by Supplier

Exhibit 3-28:     2005, Europe, Selected Percutaneous Transluminal Coronary Angioplasty Balloon Catheters

Exhibit 3-29:     Europe, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters, Market Forecast, 2004-2011

Exhibit 3-30:     France, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters, Market Forecast, 2004-2011

Exhibit 3-31:     Germany, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters, Market Forecast, 2004-2011

Exhibit 3-32:     Italy, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters, Market Forecast, 2004-2011

Exhibit 3-33:     Spain, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters, Market Forecast, 2004-2011

Exhibit 3-34:     United Kingdom, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters, Market Forecast, 2004-2011

Exhibit 3-35:     Benelux, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters, Market Forecast, 2004-2011

Exhibit 3-36:     Rest of Europe, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters, Market Forecast, 2004-2011

Exhibit 3-37:     2004, Europe, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters Market, Share by Supplier

Exhibit 3-38:     2004, France, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters Market, Share by Supplier

Exhibit 3-39:     2004, Germany, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters Market, Share by Supplier

Exhibit 3-40:     2004, Italy, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters Market, Share by Supplier

Exhibit 3-41:     2004, Spain, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters Market, Share by Supplier

Exhibit 3-42:     2004, United Kingdom, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters Market, Share by Supplier

Exhibit 3-43:     2004, Benelux, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters Market, Share by Supplier

Exhibit 3-44:     2004, Rest of Europe, Percutaneous Transluminal Coronary Angioplasty Balloon Catheters Market, Share by Supplier

Exhibit 3-45:     2005, Europe, Selected Coronary Guiding Catheters

Exhibit 3-46:     Europe, Coronary Guiding Catheters, Market Forecast, 2004-2011

Exhibit 3-47:     France, Coronary Guiding Catheters, Market Forecast, 2004-2011

Exhibit 3-48:     Germany, Coronary Guiding Catheters, Market Forecast, 2004-2011

Exhibit 3-49:     Italy, Coronary Guiding Catheters, Market Forecast, 2004-2011

Exhibit 3-50:     Spain, Coronary Guiding Catheters, Market Forecast, 2004-2011

Exhibit 3-51:     United Kingdom, Coronary Guiding Catheters, Market Forecast, 2004-2011

Exhibit 3-52:     Benelux, Coronary Guiding Catheters, Market Forecast, 2004-2011

Exhibit 3-53:     Rest of Europe, Coronary Guiding Catheters, Market Forecast, 2004-2011

Exhibit 3-54:     2004, Europe, Coronary Guiding Catheters Market, Share by Supplier

Exhibit 3-55:     2004, France, Coronary Guiding Catheters Market, Share by Supplier

Exhibit 3-56:     2004, Germany, Coronary Guiding Catheters Market, Share by Supplier

Exhibit 3-57:     2004, Italy, Coronary Guiding Catheters Market, Share by Supplier

Exhibit 3-58:     2004, Spain, Coronary Guiding Catheters Market, Share by Supplier

Exhibit 3-59:     2004, United Kingdom, Coronary Guiding Catheters Market, Share by Supplier

Exhibit 3-60:     2004, Benelux, Coronary Guiding Catheters Market, Share by Supplier

Exhibit 3-61:     2004, Rest of Europe, Coronary Guiding Catheters Market, Share by Supplier

Exhibit 3-62:     2005, Europe, Selected Coronary Guidewires

Exhibit 3-63:     Europe, Coronary Guidewires, Market Forecast, 2004-2011

Exhibit 3-64:     France, Coronary Guidewires, Market Forecast, 2004-2011

Exhibit 3-65:     Germany, Coronary Guidewires, Market Forecast, 2004-2011

Exhibit 3-66:     Italy, Coronary Guidewires, Market Forecast, 2004-2011

Exhibit 3-67:     Spain, Coronary Guidewires, Market Forecast, 2004-2011

Exhibit 3-68:     United Kingdom, Coronary Guidewires Market Forecast, 2004-2011

Exhibit 3-69:     Benelux, Coronary Guidewires, Market Forecast, 2004-2011

Exhibit 3-70:     Rest of Europe, Coronary Guidewires, Market Forecast, 2004-2011

Exhibit 3-71:     2004, Europe, Coronary Guidewires Market, Share by Supplier

Exhibit 3-72:     2004, France, Coronary Guidewires Market, Share by Supplier

Exhibit 3-73:     2004, Germany, Coronary Guidewires Market, Share by Supplier

Exhibit 3-74:     2004, Italy, Coronary Guidewires Market, Share by Supplier

Exhibit 3-75:     2004, Spain, Coronary Guidewires Market, Share by Supplier

Exhibit 3-76:     2004, United Kingdom, Coronary Guidewires Market, Share by Supplier

Exhibit 3-77:     2004, Benelux, Coronary Guidewires Market, Share by Supplier

Exhibit 3-78:     2004, Rest of Europe, Coronary Guidewires Market, Share by Supplier

Exhibit 3-79:     2005, Europe, Selected Introducers/Sheaths

Exhibit 3-80:     Europe, Introducers/Sheaths, Market Forecast, 2004-2011

Exhibit 3-81:     France, Introducers/Sheaths, Market Forecast, 2004-2011

Exhibit 3-82:     Germany, Introducers/Sheaths, Market Forecast, 2004-2011

Exhibit 3-83:     Italy, Introducers/Sheaths, Market Forecast, 2004-2011

Exhibit 3-84:     Spain, Introducers/Sheaths, Market Forecast, 2004-2011

Exhibit 3-85:     United Kingdom, Introducers/Sheaths, Market Forecast, 2004-2011

Exhibit 3-86:     Benelux, Introducers/Sheaths, Market Forecast, 2004-2011

Exhibit 3-87:     Rest of Europe, Introducers/Sheaths, Market Forecast, 2004-2011

Exhibit 3-88:     2004, Europe, Introducers/Sheaths Market, Share by Supplier

Exhibit 3-89:     2004, France, Introducers/Sheaths Market, Share by Supplier

Exhibit 3-90:     2004, Germany, Introducers/Sheaths Market, Share by Supplier

Exhibit 3-91:     2004, Italy, Introducers/Sheaths Market, Share by Supplier

Exhibit 3-92:     2004, Spain, Introducers/Sheaths Market, Share by Supplier

Exhibit 3-93:     2004, United Kingdom, Introducers/Sheaths Market, Share by Supplier

Exhibit 3-94:     2004, Benelux, Introducers/Sheaths Market, Share by Supplier

Exhibit 3-95:     2004, Rest of Europe, Introducers/Sheaths Market, Share by Supplier

Exhibit 3-96:     2005, Europe, Selected Percutaneous Transluminal Coronary Angioplasty/Stenting Inflation Devices

Exhibit 3-97:     Europe, Inflation Devices, Market Forecast, 2004-2011

Exhibit 3-98:     France, Inflation Devices, Market Forecast, 2004-2011

Exhibit 3-99:     Germany, Inflation Devices, Market Forecast, 2004-2011

Exhibit 3-100:   Italy, Inflation Devices, Market Forecast, 2004-2011

Exhibit 3-101:   Spain, Inflation Devices, Market Forecast, 2004-2011

Exhibit 3-102:   United Kingdom, Inflation Devices, Market Forecast, 2004-2011

Exhibit 3-103:   Benelux, Inflation Devices, Market Forecast, 2004-2011

Exhibit 3-104:   Rest of Europe, Inflation Devices, Market Forecast, 2004-2011

Exhibit 3-105:   2004, Europe, Inflation Devices Market, Share by Supplier

Exhibit 3-106:   2004, France, Inflation Devices Market, Share by Supplier

Exhibit 3-107:   2004, Germany, Inflation Devices Market, Share by Supplier

Exhibit 3-108:   2004, Italy Inflation Devices Market, Share by Supplier

Exhibit 3-109:   2004, Spain, Inflation Devices Market, Share by Supplier

Exhibit 3-110:   2004, United Kingdom, Inflation Devices Market, Share by Supplier

Exhibit 3-111:   2004, Benelux, Inflation Devices Market, Share by Supplier

Exhibit 3-112:   2004, Rest of Europe, Inflation Devices Market, Share by Supplier

Exhibit 3-113:   2005, Europe, Selected Arterial Access Site Closure Devices

Exhibit 3-114:   Europe, Arterial Access Site Closure Devices, Market Forecast, 2004-2011

Exhibit 3-115:   France, Arterial Access Site Closure Devices, Market Forecast, 2004-2011

Exhibit 3-116:   Germany, Arterial Access Site Closure Devices, Market Forecast, 2004-2011

Exhibit 3-117:   Italy, Arterial Access Site Closure Devices, Market Forecast, 2004-2011

Exhibit 3-118:   Spain, Arterial Access Site Closure Devices, Market Forecast, 2004-2011

Exhibit 3-119:   United Kingdom, Arterial Access Site Closure Devices, Market Forecast, 2004-2011

Exhibit 3-120:   Benelux, Arterial Access Site Closure Devices, Market Forecast, 2004-2011

Exhibit 3-121:   Rest of Europe, Arterial Access Site Closure Devices, Market Forecast, 2004-2011

Exhibit 3-122:   2004, Europe, Arterial Access Site Closure Devices Market, Share by Supplier

Exhibit 3-123:   2004, France, Arterial Access Site Closure Devices Market, Share by Supplier

Exhibit 3-124:   2004, Germany, Arterial Access Site Closure Devices Market, Share by Supplier

Exhibit 3-125:   2004, Italy, Arterial Access Site Closure Devices Market, Share by Supplier

Exhibit 3-126:   2004, Spain, Arterial Access Site Closure Devices Market, Share by Supplier

Exhibit 3-127:   2004, United Kingdom, Arterial Access Site Closure Devices Market, Share by Supplier

Exhibit 3-128:   2004, Benelux, Arterial Access Site Closure Devices Market, Share by Supplier

Exhibit 3-129:   2004, Rest of Europe, Arterial Access Site Closure Devices Market, Share by Supplier

 

4. CORONARY STENTS AND STENT SYSTEMS MARKET

4.1 Coronary Stent Designs

4.1.1 Stent Materials

4.1.1.1 Stainless Steel

4.1.1.2 Nitinol

4.1.1.3 Tantalum

4.1.1.4 Cobalt-Chromium Alloys

4.1.1.5 Magnesium-Based Alloys

4.1.1.6 Biomaterials and Biodegradable Polymers

4.1.2 Stent Coatings/Surfaces

4.1.2.1 Inert

4.1.2.1.1 Heparin

4.1.2.1.2 Carbon

4.1.2.1.3 Ionic Oxygen

4.1.2.1.4 Polymers

4.1.2.2 Drug-Eluting

4.1.2.2.1 Sirolimus-Eluting

4.1.2.2.2 Paclitaxel-Eluting

4.1.2.2.3 Everolimus-Eluting

4.1.2.2.4 ABT-578-Eluting

4.1.2.2.5 AP23573-Eluting

4.1.2.2.6 Tacrolimus-Eluting

4.1.2.2.7 Biolimus A9-Eluting

4.1.3 Stent Configurations

4.1.3.1 Coil

4.1.3.2 Tubular

4.2 Coronary Stenting

4.2.1 Stent Delivery

4.2.2 Stent Deployment

4.2.3 Indications

4.2.4 Complications

4.2.5 Clinical Trials

4.2.5.1 REALITY Trial

4.2.5.2 SIRTAX Trial

4.2.5.3 ISAR-DIABETES Trial

4.2.5.4 ARTS II Trial

4.2.5.5 TAXUS V Trial

4.2.6 Procedure Volumes

4.2.6.1 France

4.2.6.2 Germany

4.2.6.3 Italy

4.2.6.4 Spain

4.2.6.5 United Kingdom

4.2.6.6 Benelux

4.2.6.7 Rest of Europe

4.3 Coronary Stents and Stent Systems

4.3.1 Product Pricing

4.3.2 Market Overview

4.3.2.1 Market Drivers

4.3.2.2 Market Limiters

4.3.2.3 National Markets

4.3.2.4 Competitors

4.3.3 Bare-Metal Stent Products

4.3.3.1 Market Forecast

4.3.3.2 Competitive Analysis

4.3.4 Drug-Eluting Stent Products

4.3.4.1 Market Forecast

4.3.4.2 Competitive Analysis

 

Exhibit 4-1:    Europe, Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting, Historic Procedures Volumes, 1997-2003

Exhibit 4-2:    Europe, Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting, Forecast Procedures Volumes, 2004-2011

Exhibit 4-3:    Europe, Coronary Stent Placements, Historic and Forecast, 1997-2011

Exhibit 4-4:    France, Coronary Stent Placements, Historic and Forecast, 1997-2011

Exhibit 4-5:    Germany, Coronary Stent Placements, Historic and Forecast, 1997-2011

Exhibit 4-6:    Italy, Coronary Stent Placements, Historic and Forecast, 1997-2011

Exhibit 4-7:    Spain, Coronary Stent Placements, Historic and Forecast, 1997-2011

Exhibit 4-8:    United Kingdom, Coronary Stent Placements, Historic and Forecast, 1997-2011

Exhibit 4-9:    Benelux, Coronary Stent Placements, Historic and Forecast, 1997-2011

Exhibit 4-10:  Rest of Europe, Coronary Stent Placements, Historic and Forecast, 1997-2011

Exhibit 4-11:  2005, Europe, Selected Coronary Stents/Stent Systems

Exhibit 4-12:  Europe, Coronary Stents/Stent Systems, Market Forecast, 2004-2011

Exhibit 4-13:  France, Coronary Stents/Stent Systems, Market Forecast, 2004-2011

Exhibit 4-14:  Germany, Coronary Stents/Stent Systems, Market Forecast, 2004-2011

Exhibit 4-15:  Italy, Coronary Stents/Stent Systems, Market Forecast, 2004-2011

Exhibit 4-16:  Spain, Coronary Stents/Stent Systems, Market Forecast, 2004-2011

Exhibit 4-17:  United Kingdom, Coronary Stents/Stent Systems, Market Forecast, 2004-2011

Exhibit 4-18:  Benelux, Coronary Stents/Stent Systems, Market Forecast, 2004-2011

Exhibit 4-19:  Rest of Europe, Coronary Stents/Stent Systems, Market Forecast, 2004-2011

Exhibit 4-20:  2004, Europe, Coronary Stents/Stent Systems Market, Share by Supplier

Exhibit 4-21:  2004, France, Coronary Stents/Stent Systems Market, Share by Supplier

Exhibit 4-22:  2004, Germany, Coronary Stents/Stent Systems Market, Share by Supplier

Exhibit 4-23:  2004, Italy, Coronary Stents/Stent Systems Market, Share by Supplier

Exhibit 4-24:  2004, Spain, Coronary Stents/Stent Systems Market, Share by Supplier

Exhibit 4-25:  2004, United Kingdom, Coronary Stents/Stent Systems Market, Share by Supplier

Exhibit 4-26:  2004, Benelux, Coronary Stents/Stent Systems Market, Share by Supplier

Exhibit 4-27:  2004, Rest of Europe, Coronary Stents/Stent Systems Market, Share by Supplier

Exhibit 4-28:  Europe, Bare-Metal Stents, Market Forecast, 2004-2011

Exhibit 4-29:  France, Bare-Metal Stents, Market Forecast, 2004-2011

Exhibit 4-30:  Germany, Bare-Metal Stents, Market Forecast, 2004-2011

Exhibit 4-31:  Italy, Bare-Metal Stents, Market Forecast, 2004-2011

Exhibit 4-32:  Spain, Bare-Metal Stents, Market Forecast, 2004-2011

Exhibit 4-33:  United Kingdom, Bare-Metal Stents, Market Forecast, 2004-2011

Exhibit 4-34:  Benelux, Bare-Metal Stents, Market Forecast, 2004-2011

Exhibit 4-35:  Rest of Europe, Bare-Metal Stents, Market Forecast, 2004-2011

Exhibit 4-36:  2004, Europe, Bare-Metal Stents Market, Share by Supplier

Exhibit 4-37:  2004, France, Bare-Metal Stents Market, Share by Supplier

Exhibit 4-38:  2004, Germany, Bare-Metal Stents Market, Share by Supplier

Exhibit 4-39:  2004, Italy, Bare-Metal Stents Market, Share by Supplier

Exhibit 4-40:  2004, Spain, Bare-Metal Stents Market, Share by Supplier

Exhibit 4-41:  2004, United Kingdom, Bare-Metal Stents Market, Share by Supplier

Exhibit 4-42:  2004, Benelux, Bare-Metal Stents Market, Share by Supplier

Exhibit 4-43:  2004, Rest of Europe, Bare-Metal Stents Market, Share by Supplier

Exhibit 4-44:  Europe, Drug-Eluting Stents, Market Forecast, 2004-2011

Exhibit 4-45:  France, Drug-Eluting Stents, Market Forecast, 2004-2011

Exhibit 4-46:  Germany, Drug-Eluting Stents, Market Forecast, 2004-2011

Exhibit 4-47:  Italy, Drug-Eluting Stents, Market Forecast, 2004-2011

Exhibit 4-48:  Spain, Drug-Eluting Stents, Market Forecast, 2004-2011

Exhibit 4-49:  United Kingdom, Drug-Eluting Stents, Market Forecast, 2004-2011

Exhibit 4-50:  Benelux, Drug-Eluting Stents, Market Forecast, 2004-2011

Exhibit 4-51:  Rest of Europe, Drug-Eluting Stents, Market Forecast, 2004-2011

Exhibit 4-52:  2004, Europe, Drug-Eluting Stents Market, Share by Supplier

Exhibit 4-53:  2004, France, Drug-Eluting Stents Market, Share by Supplier

Exhibit 4-54:  2004, Germany, Drug-Eluting Stents Market, Share by Supplier

Exhibit 4-55:  2004, Italy, Drug-Eluting Stents Market, Share by Supplier

Exhibit 4-56:  2004, Spain, Drug-Eluting Stents Market, Share by Supplier

Exhibit 4-57:  2004, United Kingdom, Drug-Eluting Stents Market, Share by Supplier

Exhibit 4-58:  2004, Benelux, Drug-Eluting Stents Market, Share by Supplier

Exhibit 4-59:  2004, Rest of Europe, Drug-Eluting Stents Market, Share by Supplier

 

5. COMPANY PROFILES

5.1   Abbott Laboratories

5.2   BIOTRONIK GmbH & Company KG

5.3   Bolton Medical, Inc./CH-Werfen Group

5.4   Boston Scientific Corporation

5.5   B. Braun Melsungen AG

5.6   ClearStream Technologies LTD

5.7   Conor Medsystems, Inc.

5.8   Cook Group, Inc.

5.9   Cordis Corporation/Johnson & Johnson

5.10 Eucatech AG

5.11 Guidant Corporation

5.12 Hexacath

5.13 InSitu Technologies, Inc.

5.14 Medtronic, Inc.

5.15 Merit Medical Systems, Inc.

5.16 Sorin Biomedica Cardio SPA/Sorin Group SPA

5.17 St. Jude Medical, Inc

5.18 Terumo Europe NV/Terumo Corporation



COMPANIES COVERED:

  1. Abbott Laboratories
  2. BIOTRONIK GmbH & Company KG
  3. Bolton Medical, Inc./CH-Werfen Group
  4. Boston Scientific Corporation
  5. B. Braun Melsungen AG
  6. learStream Technologies LTD
  7. Conor Medsystems, Inc.
  8. Cook Group, Inc.
  9. Cordis Corporation/Johnson & Johnson
  10. Eucatech AG
  11. Guidant Corporation
  12. InSitu Technologies, Inc.
  13. Medtronic, Inc.
  14. Merit Medical Systems, Inc.
  15. Sorin Biomedica Cardio SPA/Sorin Group SPA
  16. St. Jude Medical, Inc
  17. Terumo Europe NV/Terumo Corporation
Contact Us

Need help finding medtech research? Let us help you!